AUGUSTA – The Maine Center for Disease Control and Prevention (CDC) will have the ability to complete testing much quicker with its new approved testing kits.
This comes after the state confirmed seven COVID-19 related deaths in the past week.
With 344 cases of the coronavirus, two new reported deaths from Cumberland county, the Maine CDC has taken new action with Abbott Laboratories.
The CDC reported Wednesday they will soon have a new platform for rapid diagnostic testing. Maine will be accepting 15 new Abbott Laboratories ID NOW platforms and 100 test kits.
The test kits can provide a positive test in just five minutes and a negative test in around 13 minutes.
“These Abbott platforms have been in use over the years but the kits have recently have been approved by the United States Food and Drug Administration,” Director of the CDC, Dr. Nirav Shah, said.
“From a public health perspective from a systems perspective from a Personal Protective Equipment (PPE) perspective, one of the principle benefits of having these Abbott tests will be that it can be the foundation of a PPE conservation strategy.”
Each test kit alone can produce the results for 24 tests which allows for more than just faster results.
Dr. Shah also added that these new tests will be prioritized for high risk individuals but the main goal here is conserving PPE equipment.
“Recent availability numbers for equipment such as ventilators and ICU beds have increased,” Shah said.
“The reason for that is more and more hospitals continue to report to Maine CDC, I commend and thank the hospitals for reporting those numbers to us as they are vital as we are doing our planning work,” Shah added.
Maine continues to look into alternative ways to collect the needed equipment.
For more information on Abbott’s Now ID platform and testing verification’s visit Abbott.com